Who is Claire Mazumdar? The niece set to succeed Biocon’s Kiran Mazumdar-Shaw

Kiran

Mazumdar-Shaw, founder and chairperson of Biocon, has indicated she is working on a succession plan, saying her niece Claire Mazumdar will transition into her role “at the right time” as she prepares the company for a future leadership shift.

"Claire will transition into my role at the right time so not planning to hang up my boots just yet!," Mazumdar-Shaw said on X (formerly Twitter).

Earlier in an interview with Fortune India she had said: "I am the sole owner of Biocon, and I need to make sure that I put it in good hands... I have seen my niece Claire as my successor, because I think she has proved to me that she can run a company."

The move signals the 73-year-old industry veteran’s efforts to position the firm for its next phase, with a sharper focus on advanced biotechnology and artificial intelligence (AI).

Who is Claire Mazumdar?

Claire Mazumdar is the Biocon chairperson's niece who currently heads Bicara Therapeutics, a US-based biotechnology company incubated by Biocon and listed on Nasdaq.

She has academic training in biological engineering from Massachusetts Institute of Technology (MIT) an MBA from Stanford Graduate School of Business, and a doctorate in cancer biology from Stanford School of Medicine.

She took over as CEO of Bicara in 2018 and led the company through its public listing in 2024. The firm’s market capitalisation has since crossed $1.6 billion, although its lead cancer therapy remains under clinical development, as per the Fortune India report.

Earlier, she led business development and corporate strategy at Rheos Medicines, where she played a key role in advancing a significant partnership with Roche.

She has also worked as a Senior Associate at Third Rock Ventures, where she worked on company creation and supported business development initiatives across the firm’s portfolio.

Claire now also serves on the Board of Directors of Relay Therapeutics and Noora Health, a non-profit focused on improving patient outcomes and strengthening health systems by training family caregivers.

'Claire to takeover at right time'

Reacting to the news around her successor, the Biocon chief said that she is "not planning to hang up" her boots just yet.

"Claire will transition into my role at the right time," she said in a post on X (formerly Twitter).